Lefkowitz-Kobilka Nobel 2012: GPCRs 7TM heterotrimeric Galphabetagamma activation -> beta-arrestin desensitization; ~30% of FDA drugs target GPCRs; classes A/B/C/F.
Lefkowitz-Kobilka Nobel 2012: GPCRs 7TM heterotrimeric Galphabetagamma activation -> beta-arrestin desensitization; ~30% of FDA drugs target GPCRs; classes A/B/C/F.